Mabwell Biotech is based in Shanghai, China. It has raised $300M in total funding. Latest round: Series A.
Mabwell Biotech is based in Shanghai, China. Mabwell Biotech has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2020. The round record for Mabwell Biotech runs through 2020; nothing later has been disclosed. Investors on record include Shiyu Capital, Oriental Fortune Capital, Loyal Valley Capital, Haitong Capital, Founder H Fund, Ganzhou Development Investment Fund and 6 others. 12 distinct backers are named across the disclosed rounds.
Mabwell Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026